FR2390165A1 - Nouveau medicament du type derive de glybutamide et compositions pharmaceutiques en contenant - Google Patents

Nouveau medicament du type derive de glybutamide et compositions pharmaceutiques en contenant

Info

Publication number
FR2390165A1
FR2390165A1 FR7714526A FR7714526A FR2390165A1 FR 2390165 A1 FR2390165 A1 FR 2390165A1 FR 7714526 A FR7714526 A FR 7714526A FR 7714526 A FR7714526 A FR 7714526A FR 2390165 A1 FR2390165 A1 FR 2390165A1
Authority
FR
France
Prior art keywords
glybutamide
antidiabetic
active
compsns
acetyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7714526A
Other languages
English (en)
Inventor
Maurice Joullie
Gabriel Maillard
Lucien Lakah
Charles Caulin
Christian Jean Marie Warolin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Joullie International SA
Original Assignee
Joullie International SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joullie International SA filed Critical Joullie International SA
Priority to FR7714526A priority Critical patent/FR2390165A1/fr
Publication of FR2390165A1 publication Critical patent/FR2390165A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne un nouveau médicament du type dérivé de glybutamide. Ce médicament consiste en le composé de formule :
FR7714526A 1977-05-12 1977-05-12 Nouveau medicament du type derive de glybutamide et compositions pharmaceutiques en contenant Withdrawn FR2390165A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7714526A FR2390165A1 (fr) 1977-05-12 1977-05-12 Nouveau medicament du type derive de glybutamide et compositions pharmaceutiques en contenant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7714526A FR2390165A1 (fr) 1977-05-12 1977-05-12 Nouveau medicament du type derive de glybutamide et compositions pharmaceutiques en contenant

Publications (1)

Publication Number Publication Date
FR2390165A1 true FR2390165A1 (fr) 1978-12-08

Family

ID=9190712

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7714526A Withdrawn FR2390165A1 (fr) 1977-05-12 1977-05-12 Nouveau medicament du type derive de glybutamide et compositions pharmaceutiques en contenant

Country Status (1)

Country Link
FR (1) FR2390165A1 (fr)

Similar Documents

Publication Publication Date Title
ZA906972B (en) Dosage form for administering oral hypoglycemic glipizide
EP0508488A3 (fr) Utilisation de l'inositol-triphosphate pour le traitement des maladies associées aux intoxications par des métaux
EP0427247A3 (en) Pharmaceutical composition with r-alpha-lipoic acid or s-alpha-lipoic acid as the active ingredient
DE3065342D1 (en) Chromium acetylacetonate as a dietary supplement and pharmaceutical agent
ZA911471B (en) The use of guanidine derivatives for the preparation of a pharmaceutical product having pny antagonistic activity
KR920017655A (ko) 상처의 치료를 촉진시키기 위한 약학 조성물
EP0019403A3 (en) Hydroxyalkyl-starch drug carrier and method of administering a biologically active compound to an animal
NZ332105A (en) Medicaments including human growth hormone for the treatment of type II diabetes and metabolic syndrome
MXPA05005848A (es) Uso de acidos alfa-feniltiocarboxilicos y alfa-feniloxicarboxilicos con actividad reductora de la glucosa en suero y reductora de lipidos en el suero.
FR2390165A1 (fr) Nouveau medicament du type derive de glybutamide et compositions pharmaceutiques en contenant
EP0270046A3 (en) Pharmaceutical composition for treatment of cataract
ES2166406T3 (es) Uso de derivados de 1,5-benzodiazepina para el control del vaciado gastrico en pacientes con diabetes mellitus no dependiente de insulina.
ES8203882A1 (es) Un procedimiento para la preparacion de 1-(8-quinole- il)-2-pirrolidinona y sus sales de adicion de acido
FR2244481A1 (en) Oral treatment of diabetes - with a complex of glibenclamide and phenformin
JPS6485914A (en) Use of n-(2-(diethylamino)ethyl)-2-methoxy-4- ((1-h-4,5-dihydro-2-imidazolyl)amino)-5- chlorobenzamide as antianxiety and antipsychotic
JPS57114512A (en) Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative
KR920019349A (ko) 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도
SU712090A1 (ru) Средство, угнетающее сократительную де тельность матки
JPS5675428A (en) Hypoglycemic agent containing procainamide hydrochloride
DE3688503D1 (de) Erhoehung des ausfliessens waessriger koerperfluessigkeit.
GB1449043A (en) Treatment of asthma
KR900016130A (ko) 2-피리딜메틸티오 유도체 및 궤양 치료제
ES383340A1 (es) Procedimiento para la preparacion de nuevos derivados de lap-aminoalquil-bencensulfonamida.
FR2237631A1 (en) Ethyl benzthiazole-2-carbamates - for use as anthelmintics in man and animals
FR2329260A1 (fr) Nouvelles pierres a lecher

Legal Events

Date Code Title Description
ST Notification of lapse